126 related articles for article (PubMed ID: 38014218)
1. Human brain glycoform co-regulation network and glycan modification alterations in Alzheimer's disease.
Zhang Q; Ma C; Chin LS; Pan S; Li L
bioRxiv; 2023 Nov; ():. PubMed ID: 38014218
[TBL] [Abstract][Full Text] [Related]
2. Human brain glycoform coregulation network and glycan modification alterations in Alzheimer's disease.
Zhang Q; Ma C; Chin LS; Pan S; Li L
Sci Adv; 2024 Apr; 10(14):eadk6911. PubMed ID: 38579000
[TBL] [Abstract][Full Text] [Related]
3. Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer's Disease Brain.
Suttapitugsakul S; Stavenhagen K; Donskaya S; Bennett DA; Mealer RG; Seyfried NT; Cummings RD
Mol Cell Proteomics; 2022 Dec; 21(12):100433. PubMed ID: 36309312
[TBL] [Abstract][Full Text] [Related]
4. Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer's disease.
Zhang Q; Ma C; Chin LS; Li L
Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008897
[TBL] [Abstract][Full Text] [Related]
5. In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.
Chen Z; Yu Q; Yu Q; Johnson J; Shipman R; Zhong X; Huang J; Asthana S; Carlsson C; Okonkwo O; Li L
Mol Cell Proteomics; 2021; 20():100081. PubMed ID: 33862227
[TBL] [Abstract][Full Text] [Related]
6. Glycoproteomics of a Single Protein: Revealing Tens of Thousands of Myozyme Glycoforms by Hybrid HPLC-MS Approaches.
Di Marco F; Blöchl C; Esser-Skala W; Schäpertöns V; Zhang T; Wuhrer M; Sandra K; Wohlschlager T; Huber CG
Mol Cell Proteomics; 2023 Sep; 22(9):100622. PubMed ID: 37478974
[TBL] [Abstract][Full Text] [Related]
7. N-glycan and Alzheimer's disease.
Kizuka Y; Kitazume S; Taniguchi N
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
[TBL] [Abstract][Full Text] [Related]
8. Site- and structure-specific characterization of the human urinary N-glycoproteome with site-determining and structure-diagnostic product ions.
Shen Y; Xiao K; Tian Z
Rapid Commun Mass Spectrom; 2021 Jan; 35(1):e8952. PubMed ID: 32965048
[TBL] [Abstract][Full Text] [Related]
9. High-resolution glycoform profiling of intact therapeutic proteins by hydrophilic interaction chromatography-mass spectrometry.
Domínguez-Vega E; Tengattini S; Peintner C; van Angeren J; Temporini C; Haselberg R; Massolini G; Somsen GW
Talanta; 2018 Jul; 184():375-381. PubMed ID: 29674057
[TBL] [Abstract][Full Text] [Related]
10. Human Brain and Blood N-Glycome Profiling in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
Yu L; Huo Z; Yang J; Palma-Gudiel H; Boyle PA; Schneider JA; Bennett DA; Zhao J
Front Aging Neurosci; 2021; 13():765259. PubMed ID: 34776937
[TBL] [Abstract][Full Text] [Related]
11. Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairment.
Lundström SL; Yang H; Lyutvinskiy Y; Rutishauser D; Herukka SK; Soininen H; Zubarev RA
J Alzheimers Dis; 2014; 38(3):567-79. PubMed ID: 24028868
[TBL] [Abstract][Full Text] [Related]
12. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
[TBL] [Abstract][Full Text] [Related]
13. Distinct patterns of plaque and microglia glycosylation in Alzheimer's disease.
Fastenau C; Bunce M; Keating M; Wickline J; Hopp SC; Bieniek KF
Brain Pathol; 2024 May; 34(4):e13267. PubMed ID: 38724175
[TBL] [Abstract][Full Text] [Related]
14. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
[TBL] [Abstract][Full Text] [Related]
15. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.
Dwyer CA; Katoh T; Tiemeyer M; Matthews RT
J Biol Chem; 2015 Apr; 290(16):10256-73. PubMed ID: 25737452
[TBL] [Abstract][Full Text] [Related]
16. Systems analysis of singly and multiply O-glycosylated peptides in the human serum glycoproteome via EThcD and HCD mass spectrometry.
Zhang Y; Xie X; Zhao X; Tian F; Lv J; Ying W; Qian X
J Proteomics; 2018 Jan; 170():14-27. PubMed ID: 28970103
[TBL] [Abstract][Full Text] [Related]
17. N-glycan occupancy of Arabidopsis N-glycoproteins.
Song W; Mentink RA; Henquet MG; Cordewener JH; van Dijk AD; Bosch D; America AH; van der Krol AR
J Proteomics; 2013 Nov; 93():343-55. PubMed ID: 23994444
[TBL] [Abstract][Full Text] [Related]
18. Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody.
Falck D; Thomann M; Lechmann M; Koeleman CAM; Malik S; Jany C; Wuhrer M; Reusch D
MAbs; 2021; 13(1):1865596. PubMed ID: 33382957
[TBL] [Abstract][Full Text] [Related]
19. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
[TBL] [Abstract][Full Text] [Related]
20. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
